Funding

Transcripta Bio

United States · Biotech · AI

AI-powered drug discovery company developing treatments for neurological and neuromuscular diseases

Visit transcriptabio.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$24MBlueYard Capital — Role not disclosedJAZZ Venture Partners — Role not disclosedMayo Clinic — Role not disclosedOmnimed — Role not disclosed

Investors

BlueYard CapitalSeries AJAZZ Venture PartnersSeries AMayo ClinicSeries AOmnimedSeries A

Coverage

Jul 22, 2026Transcripta Bio · Series A

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcestranscriptabio.com ↗